Ex Vivo Generation of CAR Macrophages from Hematopoietic Stem and Progenitor Cells for Use in Cancer Therapy

Chimeric antigen receptor (CAR) T-cell therapies have shown impressive results in patients with hematological malignancies; however, little success has been achieved in the treatment of solid tumors. Recently, macrophages (MΦs) were identified as an additional candidate for the CAR approach, and ini...

Descripción completa

Detalles Bibliográficos
Autores principales: Paasch, Daniela, Meyer, Johann, Stamopoulou, Andriana, Lenz, Daniela, Kuehle, Johannes, Kloos, Doreen, Buchegger, Theresa, Holzinger, Astrid, Falk, Christine S., Kloth, Christina, von Kaisenberg, Constantin S., Abken, Hinrich, Schambach, Axel, Lachmann, Nico, Morgan, Michael, Moritz, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947001/
https://www.ncbi.nlm.nih.gov/pubmed/35326445
http://dx.doi.org/10.3390/cells11060994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947001/
https://www.ncbi.nlm.nih.gov/pubmed/35326445
http://dx.doi.org/10.3390/cells11060994

Ejemplares similares